Amwill Health Care Ltd
Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products[1]
- Market Cap ₹ 83.0 Cr.
- Current Price ₹ 41.5
- High / Low ₹ 63.4 / 28.9
- Stock P/E 7.26
- Book Value ₹ 40.3
- Dividend Yield 1.20 %
- ROCE 20.5 %
- ROE 15.3 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.03 times its book value
- Company has delivered good profit growth of 68.1% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.9%
Cons
- Company has high debtors of 177 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 17 | 26 | 28 | 42 | 37 | 43 | |
| 18 | 22 | 24 | 25 | 26 | 30 | |
| Operating Profit | -1 | 4 | 4 | 17 | 12 | 13 |
| OPM % | -6% | 14% | 15% | 40% | 31% | 30% |
| 0 | -0 | 0 | 0 | 1 | 3 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit before tax | -1 | 3 | 4 | 17 | 12 | 15 |
| Tax % | -3% | 23% | 25% | 25% | 10% | 26% |
| -1 | 3 | 3 | 12 | 11 | 11 | |
| EPS in Rs | -333.33 | 856.67 | 1,036.67 | 2,500.00 | 5.36 | 5.71 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 9% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 15% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 68% |
| 3 Years: | 54% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 31% |
| 3 Years: | 27% |
| Last Year: | 15% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.03 | 0.03 | 0.03 | 0.05 | 20 | 20 |
| Reserves | -1 | 1 | 5 | 17 | 49 | 61 |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| 9 | 5 | 8 | 2 | 2 | 6 | |
| Total Liabilities | 8 | 7 | 12 | 19 | 71 | 87 |
| 1 | 0 | 1 | 1 | 1 | 1 | |
| CWIP | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 3 |
| 7 | 6 | 12 | 18 | 70 | 83 | |
| Total Assets | 8 | 7 | 12 | 19 | 71 | 87 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 0 | 3 | 5 | -3 | 6 | 8 | |
| -1 | -0 | -1 | -1 | -46 | 6 | |
| 0 | 0 | -0 | -0 | 41 | -0 | |
| Net Cash Flow | -1 | 3 | 3 | -4 | 1 | 14 |
| Free Cash Flow | -1 | 3 | 4 | -4 | 5 | 7 |
| CFO/OP | -26% | 108% | 135% | 6% | 62% | 88% |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 93 | 12 | 16 | 114 | 163 | 177 |
| Inventory Days | 66 | |||||
| Days Payable | 39 | |||||
| Cash Conversion Cycle | 93 | 12 | 16 | 141 | 163 | 177 |
| Working Capital Days | -45 | -25 | -38 | 111 | 166 | 158 |
| ROCE % | 1,069% | 133% | 153% | 28% | 21% |
Insights
In beta| Mar 2024 | Mar 2025 | |
|---|---|---|
| Hair Care Revenue Mix % of total revenue |
|
|
| Lip Care Revenue Mix % of total revenue |
||
| Personal Care & Hygiene Revenue Mix % of total revenue |
||
| Sales and Marketing Team Size count |
||
| Skin Care Revenue Mix % of total revenue |
||
| Total Employees count |
||
| Number of States Covered count |
||
| Total Number of Products (SKUs) count |
||
Extracted by Screener AI
Documents
Announcements
-
Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation, 2015
- Investment Committee approved up to ₹33 crore across debt, equities, IPOs, AIFs, invoice discounting and mutual funds.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Board approved FY26 annual report, AGM on August 14, 2026, and reappointed two MDs from January 27, 2027.
-
Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation, 2015
- Approved Rs 2 crore fixed deposit with Vysya Co-operative Bank in Bangalore.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication - Notice of 9th Annual General Meeting of Amwill Health Care Limited , evoting and other Information
-
Notice Of The Ninth Annual General Meeting For The Financial Year 2025-26
- AGM on August 14, 2026; FY26 annual report filed, ₹0.50 final dividend proposed, MD reappointments sought.
Business Overview:[1][2]
a) AHL focuses on Dermatology, Trichology, and Cosmetology.
b) It creates advanced skincare solutions using dermatological actives, natural ingredients, and specialized techniques.
c) Operates as a dermal-cosmetic developer, collaborating with contract manufacturers, distributors, and third-party developers.
d) Follows an asset-light model, outsourcing testing, manufacturing, and distribution.